GMGiuseppe Martorana

Giuseppe Martorana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Giuseppe Martorana has a total of 137 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Case of Prostate Cancer Recurrence in the Bladder Wall after Radical Prostatectomy: The Role of Diffusion-Weighted and Dynamic Contrast-Enhanced Magnetic Resonance Imaging

    by Caterina Gaudiano, Fiorenza Busato, Carlo Cecchelli, Riccardo Schiavina, Eugenio Brunocilla, Giuseppe Martorana, Rita Golfieri

    The authors report a case of prostate cancer recurrence in the bladder wall after radical prostatectomy studied by magnetic resonance imaging with diffusion weighted and dynamic contrast-enhanced sequences.

    • 1 April 2015
      • Vol. 68  (3) , 354-70

    State of the art of PET/CT with 11-choline and 18F-fluorocholine in the diagnosis and follow-up of localized and locally advanced prostate cancer.

    by Valerio Vagnoni, Eugenio Brunocilla, Lorenzo Bianchi, Angelo Porreca, Marco Borghesi, Cristian Vincenzo Pultrone, Porreca Angelo, Francesco Chessa, Francesco Ceci, Francesco Mengoni, et al.

    To provide an updated state of the art about the role of positron emission tomography/computed tomography (PET/CT) with 11C-Choline and 18F-fluorocholine in the localized and locally advanced Prostate Cancer (PCa) in the staging and restaging setting. We performed a non-systematic review of the literature based on a free-text search in the National Library of Medicine Database (MEDLINE) to select English-language published papers evaluating PET and PET/CT imaging with radiolabelled choline in initial diagnosis and in post-treatment phase in PCa patients. PET and PET/CT with 11C-choline and 18F-fluorocholine have been largely investigated as non-invasive diagnostic tools in PCa. Actually, the relatively high rate of false negative findings due to the small dimension of neoplastic lesions and the available spatial resolution of PET tracers limits the routine use of choline PET and PET/CT in staging setting; moreover, it cannot reliably replace the lymph node (LN) dissection for detecting LN involvement. On restaging setting, Choline PET/CT showed a higher accuracy than conventional imaging modalities, especially in the detection of LN and systemic metastases, while it is less accurate than magnetic resonance imaging in the detection of local relapse. In the Prostate Specific Antigen (PSA) era with a large number of localized disease, the diagnostic performance of choline PET and PET/CT lack of reliability in initial diagnosis of PCa. The major clinical role of choline PET/CT is the re-staging of patients with a biochemical relapse after radical treatment; the promising performance of choline PET/CT scan in patients with low levels of PSA could also lead the clinicians for to perform PET-guided adjuvant curative therapies or palliative treatments in patients already treated radically for PCa.


  • Open Access

    First case of 18F-FACBC PET/CT-guided salvage radiotherapy for local relapse after radical prostatectomy with negative 11C-Choline PET/CT and multiparametric MRI: New imaging techniques may improve patient selection

    by Eugenio Brunocilla, Riccardo Schiavina, Cristina Nanni, Marco Borghesi, Matteo Cevenini, Enrico Molinaroli, Valerio Vagnoni, Paolo Castellucci, Francesco Ceci, Stefano Fanti, et al.

    We present the first case of salvage radiotherapy based on the results of 18F-FACBC PET/CT performed for a PSA relapse after radical prostatectomy. The patients underwent 11CCholine PET/CT and multiparametric MRI that were negative while 18F-FACBC PET/CT visualized a suspected local relapse confirmed by transrectal ultrasound-guided biopsy. No distant relapse was detected. Thus the patient was submitted to salvage radiotherapy in the prostatic fossa. After 20 months of follow-up, the PSA was undetectable and 18F-FACBC PET/CT was negative. Salvage radiotherapy after surgery, provided that it is administered at the earliest evidence of the biochemical relapse, may improve cancer control and favourably influence the course of disease as well as the adjuvant approach. New imaging techniques may increase the efficacy of the salvage radiotherapy thus helping in the selection of the patients. Preliminary clinical reports showed an improvement in the detection rate of 20-40% of 18F-FACBC in comparison with 11C-Choline for the detection of disease relapse after radical prostatecomy, rendering the 18F-FACBC the potential radiotracer of the future for prostate cancer.


    • 8 July 2014
      • Vol. 11  (3) , 1724-6

    Uretero-caval fistula after radical cystectomy with bricker ileal conduit: a case report.

    by Cristian Vincenzo Pultrone, Riccardo Schiavina, Eugenio Brunocilla, Caterina Gaudiano, Matteo Renzulli, Valerio Vagnoni, Fiorenza Busato, Marco Borghesi, Giuseppe Martorana


  • Open Access

    Robot-assisted partial nephrectomy: Excellent results even in more complex renal tumours

    by Marco Borghesi, Riccardo Schiavina, Giuseppe Martorana, Eugenio Brunocilla

    Robot-assisted partial nephrectomy: Excellent results even in more complex renal tumours

    • 1 May 2014
      • Vol. 34  (5) , 2443-8

    Laparoscopic radical prostatectomy: 10 years of experience at a single institution.

    by Fabio Manferrari, Eugenio Brunocilla, Alessandro Baccos, Alessandro Bertaccini, Marco Garofalo, Marco Borghesi, Riccardo Schiavina, Giuseppe Martorana

    The Urological Clinic of the S. Orsola-Malpighi University Hospital, Bologna has been carrying out laparoscopic radical prostatectomy since 2002. In this study, we report the results after 10 years of LRP, analyzing in particular the oncological and functional aspects. Between March 2002 and August 2011, 400 patients underwent laparoscopic radical prostatectomy. Cancer control, recovery of continence and potency were evaluated at 1, 3, 6 and 12 months. All data were retrospectively collected on the basis of thorough clinical and pathological examination. Follow-up ranged from 10 to 122 months. Pathological examination revealed pT2 and pT3 cancers in 63.5% and 36.5% of patients, respectively. The incidence of positive surgical margins and biochemical relapse rate was 33.8% and 12.0%, respectively. 10 Years after the first laparoscopic radical prostatectomy was performed at our Center, we can state that it is a reliable alternative to traditional surgery, with satisfactory oncological and functional results.

    • 1 November 2013
      • Vol. 33  (11) , 5205-10

    Testis-sparing surgery for the conservative management of small testicular masses: an update.

    by Eugenio Brunocilla, Giorgio Gentile, Riccardo Schiavina, Marco Borghesi, Alessandro Franceschelli, Cristian Vincenzo Pultrone, Francesco Chessa, Daniele Romagnoli, Sadam Mahmoud Ghanem, Mauro Gacci, et al.

    Malignant germ cell tumours represent the vast majority of palpable testicular masses, and radical orchiectomy is still considered the standard-of-care. Testis-sparing surgery (TSS) could be an alternative to radical orchiectomy in patients diagnosed with small testicular masses (STMs). The aim of this article was to review the current indications and the oncological and functional outcomes of TSS when performed for STMs. We performed a non-systematic review of literature using the Medline database, including a free-text protocol using the terms "testis sparing surgery", "partial orchiectomy", "testis tumour" and "sex cord tumour". Only the articles reporting data on organ-sparing surgery for testicular neoplasms were evaluated. No randomized controlled trials comparing TSS with radical orchiectomy have been reported. Indications for TSS are controversial, especially for patients with normal contra-lateral testis. For testicular masses of less then 2 cm, TSS seems to be the best treatment option. Frozen-section examination is an essential assessment at the time of TSS, and allows for discrimination of benign from malignant neoplasms. Intermediate- and long-term follow-up results showed no significant risk of local and distant recurrences in the main series reported in literature. According to currently available data, TSS is a safe and effective treatment for STMs in selected patients, and bypasses surgical overtreatment, without compromising oncological and functional outcomes. Further studies are needed in order to confirm the oncological safety of this procedure.


  • Open Access

    Massive hematuria due to ruptured iatrogenic aortic pseudoaneurysm: A case report

    by Valerio Vagnoni, Caterina Gaudiano, Giovanni Passaretti, Riccardo Schiavina, Eugenio Brunocilla, Cristian Vincenzo Pultrone, Marco Borghesi, Giuseppe Martorana

    We report an interesting case of massive haematuria secondary to a rupture of a pseudoa- neurysm of the abdominal aorta below the renal vessels. A 65-year-old woman present- ed at our institution with a painful massive haematuria and anaemia. Two months before, she undergone a pelvic surgery complicated by an accidental injury of the right ureter sutured with a end-to-end anastomosis. An abdominal computed tomography (CT) scan with intravenous contrast showed a right-sided hydronephrosis with clots in the lumen of the right pelvis with a massive retroperitoneal hematoma due to a rupture of a iatrogenic pseudoaneurysm of the abdominal aorta below the origin of the renal arteries.


    • 1 June 2013
      • Vol. 33  (6) , 2361-8

    Inguinal canal tumors of adulthood.

    by Valerio Vagnoni, Eugenio Brunocilla, Riccardo Schiavina, Marco Borghesi, Giovanni Passaretti, Giorgio Gentile, Michelangelo Fiorentino, Giuseppe Martorana

    To review benign and malignant paratesticular lesions. A non-systematic review of the English literature in the National Library of Medicine Database (MEDLINE) was performed using the key words "spermatic cord", "inguinal canal", "neoplasms" (focusing on soft tissue sarcomas). The 74 most significant contributions were selected. Although generally benign (lipoma is the most frequent), paratesticular tumors have a high incidence of malignancy (30%). Ultrasonography, computed tomography and magnetic resonance imaging represent the main tools in the evaluation of a solid paratesticular mass. Most malignant tumors are sarcomas and commonly spread via local invasion to adjacent structures. The definitive diagnosis is made postoperatively. Surgical excision in the form of radical orchiectomy and wide local resection of tumor margins is mandatory and represents the mainstay of treatment options. Surgical treatment of paratesticular tumors is fundamental in order to determine the histology so as to define the correct follow-up for each patient.